Home > News > Lung Cancer News Articles > New Personalized Medicine for Alk-positive or Metatstic Non Small Cell Lung Cancer
Print this page Tell A Friend Add to Favorites

New Personalized Medicine for Alk-positive or Metatstic Non Small Cell Lung Cancer

Pfizer Canada announces new drug Xalkori (cirzotinib) is now available in Canada.
 
 

Quick Links

Privacy Policy | Site Map | Sign Up for Our Newsletter | Board Members

CONTACT INFORMATION

Lung Cancer Canada
10 St. Mary Street
Suite 315
Toronto, ON M4Y 1P9




info@lungcancercanada.ca
Telephone: 416-785-3439
Toll Free: 1-888-445-4403
Fax: 416-785-2905

Site by Inorbital